281 related articles for article (PubMed ID: 25425577)
1. A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity.
Kim DH; Xiao Z; Kwon S; Sun X; Ryerson D; Tkac D; Ma P; Wu SY; Chiang CM; Zhou E; Xu HE; Palvimo JJ; Chen LF; Kemper B; Kemper JK
EMBO J; 2015 Jan; 34(2):184-99. PubMed ID: 25425577
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.
Santana AC; Degaspari S; Catanozi S; Dellê H; de Sá Lima L; Silva C; Blanco P; Solez K; Scavone C; Noronha IL
Nephrol Dial Transplant; 2013 May; 28(5):1140-9. PubMed ID: 23345625
[TBL] [Abstract][Full Text] [Related]
4. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine.
Gadaleta RM; Oldenburg B; Willemsen EC; Spit M; Murzilli S; Salvatore L; Klomp LW; Siersema PD; van Erpecum KJ; van Mil SW
Biochim Biophys Acta; 2011 Aug; 1812(8):851-8. PubMed ID: 21540105
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice.
Lee J; Seok S; Yu P; Kim K; Smith Z; Rivas-Astroza M; Zhong S; Kemper JK
Hepatology; 2012 Jul; 56(1):108-17. PubMed ID: 22278336
[TBL] [Abstract][Full Text] [Related]
6. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
[TBL] [Abstract][Full Text] [Related]
7. Transcription Factor hDREF Is a Novel SUMO E3 Ligase of Mi2α.
Yamashita D; Moriuchi T; Osumi T; Hirose F
J Biol Chem; 2016 May; 291(22):11619-34. PubMed ID: 27068747
[TBL] [Abstract][Full Text] [Related]
8. A CK2-RNF4 interplay coordinates non-canonical SUMOylation and degradation of nuclear receptor FXR.
Bilodeau S; Caron V; Gagnon J; Kuftedjian A; Tremblay A
J Mol Cell Biol; 2017 Jun; 9(3):195-208. PubMed ID: 28201649
[TBL] [Abstract][Full Text] [Related]
9. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice.
Martin IV; Schmitt J; Minkenberg A; Mertens JC; Stieger B; Mullhaupt B; Geier A
Biol Chem; 2010 Dec; 391(12):1441-9. PubMed ID: 20868235
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
[TBL] [Abstract][Full Text] [Related]
11. The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression.
Bijsmans IT; Guercini C; Ramos Pittol JM; Omta W; Milona A; Lelieveld D; Egan DA; Pellicciari R; Gioiello A; van Mil SW
Sci Rep; 2015 Sep; 5():14086. PubMed ID: 26369990
[TBL] [Abstract][Full Text] [Related]
12. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
Mabb AM; Wuerzberger-Davis SM; Miyamoto S
Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
[TBL] [Abstract][Full Text] [Related]
13. SUMO E3 Ligase PIASy Mediates High Glucose-Induced Activation of NF-
Huang W; Liang Y; Dong J; Zhou L; Gao C; Jiang C; Chen M; Long Y; Xu Y
Mediators Inflamm; 2017; 2017():1685194. PubMed ID: 29038616
[TBL] [Abstract][Full Text] [Related]
14. FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
Kemper JK; Xiao Z; Ponugoti B; Miao J; Fang S; Kanamaluru D; Tsang S; Wu SY; Chiang CM; Veenstra TD
Cell Metab; 2009 Nov; 10(5):392-404. PubMed ID: 19883617
[TBL] [Abstract][Full Text] [Related]
15. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
16. Acetylation of SUMO2 at lysine 11 favors the formation of non-canonical SUMO chains.
Gärtner A; Wagner K; Hölper S; Kunz K; Rodriguez MS; Müller S
EMBO Rep; 2018 Nov; 19(11):. PubMed ID: 30201799
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation attenuates the transcriptional activity of the NF-κB subunit RelB.
Leidner J; Voogdt C; Niedenthal R; Möller P; Marienfeld U; Marienfeld RB
J Cell Biochem; 2014 Aug; 115(8):1430-40. PubMed ID: 24616021
[TBL] [Abstract][Full Text] [Related]
18. The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFκB into the nucleus.
Kim EM; Lee HH; Kim SH; Son YO; Lee SJ; Han J; Bae J; Kim SJ; Park CG; Park Y; Hwang KW; Chun T
Mol Immunol; 2011 Sep; 48(15-16):2189-97. PubMed ID: 21632113
[TBL] [Abstract][Full Text] [Related]
19. Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice.
Lu Y; Ma Z; Zhang Z; Xiong X; Wang X; Zhang H; Shi G; Xia X; Ning G; Li X
Gut; 2014 Jan; 63(1):170-8. PubMed ID: 23348961
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation differentially regulates Sp1 to control cell differentiation.
Gong L; Ji WK; Hu XH; Hu WF; Tang XC; Huang ZX; Li L; Liu M; Xiang SH; Wu E; Woodward Z; Liu YZ; Nguyen QD; Li DW
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5574-9. PubMed ID: 24706897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
